{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-017615","form_type":"8-K","ticker":"IMCR","cik":"0001671927","company_name":"Immunocore Holdings plc","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.284473+00:00","generated_at":"2026-05-22T08:23:48.193707+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Immunocore Q1: KIMMTRAK revenue $93.9M (+33% YoY); net income $5M vs loss year ago","bullets":["KIMMTRAK net sales $93.9M, up 33% YoY; US $56.6M, Europe $32.8M (incl $6M favorable adjustments), intl $4.5M.","Net income $5.0M vs net loss $24.4M in Q1 2024; diluted EPS $0.10 vs ($0.49).","Phase 3 TEBE-AM (cutaneous melanoma) enrollment on track to complete in 1H 2026; PRISM-MEL-301 dose selection expected 2H 2025.","HIV candidate IMC-M113V showed viral control in 3 of 15 evaluable patients at CROI; dose escalation continuing.","Cash and securities $837M at March 31, 2025, up from $820.4M at Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-017615","json":"https://secwatch.observer/filing/0001140361-25-017615.json","markdown":"https://secwatch.observer/filing/0001140361-25-017615.md","text":"https://secwatch.observer/filing/0001140361-25-017615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671927/000114036125017615/0001140361-25-017615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671927/000114036125017615/ef20048471_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T08:23:48.193707+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}